The expression of NAMPT is increased in urothelial carcinoma, breast cancer, stomach cancer, esophageal cancer, colorectal cancer (CRC), ovarian cancer, prostate cancer, glioblastoma, and melanoma. Here, NAMPT is linked to colorectal carcinoma.